Latest news
Loading news…
Tusk Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Stevenage, Herefordshire, United Kingdom Founded 2014 11-50 employees For Profit
Tusk Tx focuses on discovering & developing unique therapeutic antibodies that harness the immune system for the treatment of cancer
Tusk Therapeutics was acquired by Roche in 2018 for $758M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
27
1 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Active products
- 19
- Patents granted
- 27
- Trademarks
- 1
- Top patent class
- Medical Or Veterinary Science; Hygiene
Company Info
- Founded
- 2014
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 9
- HQ
- Stevenage, Herefordshire, United Kingdom
- Region
- Europe, Middle East, and Africa (EMEA)
- Exit date
- Sep 28, 2018
Signals & Scores
- Heat score
- Medium
- Trend (7d)
- -0.1
- Trend (30d)
- -0.3
- Trend (90d)
- -0.8
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Tusk Therapeutics
Loading news…
FAQs about Tusk Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.